From the Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital, MN (J.H.T., T.D.H., J.F., Y.L.W., I.J.C., D.L.L., J.R.L., W.R.P., N.M.B., A.P., J.L.L., R.F.G.).
Cardiovascular Division, The University of Minnesota School of Medicine, Minneapolis (J.H.T., C.M.S.).
Circ Res. 2019 Mar;124(5):769-778. doi: 10.1161/CIRCRESAHA.118.314060.
Postconditioning at the time of primary percutaneous coronary intervention (PCI) for ST-segment-elevation myocardial infarction may reduce infarct size and improve myocardial salvage. However, clinical trials have shown inconsistent benefit.
We performed the first National Heart, Lung, and Blood Institute-sponsored trial of postconditioning in the United States using strict enrollment criteria to optimize the early benefits of postconditioning and assess its long-term effects on left ventricular (LV) function.
We randomized 122 ST-segment-elevation myocardial infarction patients to postconditioning (4, 30 seconds PTCA [percutaneous transluminal coronary angioplasty] inflations/deflations)+PCI (n=65) versus routine PCI (n=57). All subjects had an occluded major epicardial artery (thrombolysis in myocardial infarction=0) with ischemic times between 1 and 6 hours with no evidence of preinfarction angina or collateral blood flow. Cardiac magnetic resonance imaging measured at 2 days post-PCI showed no difference between the postconditioning group and control in regards to infarct size (22.5±14.5 versus 24.0±18.5 g), myocardial salvage index (30.3±15.6% versus 31.5±23.6%), or mean LV ejection fraction. Magnetic resonance imaging at 12 months showed a significant recovery of LV ejection fraction in both groups (61.0±11.4% and 61.4±9.1%; P<0.01). Subjects randomized to postconditioning experienced more favorable remodeling over 1 year (LV end-diastolic volume =157±34 to 150±38 mL) compared with the control group (157±40 to 165±45 mL; P<0.03) and reduced microvascular obstruction ( P=0.05) on baseline magnetic resonance imaging and significantly less adverse LV remodeling compared with control subjects with microvascular obstruction ( P<0.05). No significant adverse events were associated with the postconditioning protocol and all patients but one (hemorrhagic stroke) survived through 1 year of follow-up.
We found no early benefit of postconditioning on infarct size, myocardial salvage index, and LV function compared with routine PCI. However, postconditioning was associated with improved LV remodeling at 1 year of follow-up, especially in subjects with microvascular obstruction.
URL: http://www.clinicaltrials.gov . Unique identifier: NCT01324453.
ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗(PCI)时的后处理可能会缩小梗死面积并改善心肌挽救。然而,临床试验结果不一致。
我们在美国进行了首次由美国国立心肺血液研究所(National Heart, Lung, and Blood Institute)资助的后处理临床试验,采用严格的纳入标准,以优化后处理的早期获益,并评估其对左心室(LV)功能的长期影响。
我们将 122 例 ST 段抬高型心肌梗死患者随机分为后处理组(4 次,每次 30 秒 PTCA[经皮腔内冠状动脉成形术]充气/放气)+PCI(n=65)和常规 PCI 组(n=57)。所有患者的主要心外膜动脉均有阻塞(心肌梗死溶栓治疗分类=0),缺血时间为 1 至 6 小时,无梗死前心绞痛或侧支血流证据。PCI 后 2 天的心脏磁共振成像显示,后处理组与对照组在梗死面积(22.5±14.5 与 24.0±18.5 g)、心肌挽救指数(30.3±15.6%与 31.5±23.6%)或平均 LV 射血分数方面均无差异。12 个月的磁共振成像显示,两组的 LV 射血分数均有显著恢复(61.0±11.4%和 61.4±9.1%;P<0.01)。与对照组相比(LV 舒张末期容积=157±34 至 150±38 mL),接受后处理的患者在 1 年内经历了更有利的重构(157±40 至 150±38 mL;P<0.03),并减少了微血管阻塞(P=0.05)。在基线磁共振成像上,与无微血管阻塞的对照组相比,接受后处理的患者有显著较少的不良 LV 重构(P<0.05)。与后处理方案相关的不良事件不明显,所有患者(除 1 例出血性卒中)均存活至 1 年随访。
与常规 PCI 相比,我们未发现后处理对梗死面积、心肌挽救指数和 LV 功能有早期获益。然而,后处理与 1 年随访时的 LV 重构改善相关,尤其是在有微血管阻塞的患者中。